CytoMed Therapeutics
(NASDAQ) GDTC
CytoMed Therapeutics Financials at a Glance
Market Cap
$11.83M
Revenue (TTM)
$388.79K
Net Income (TTM)
$4.14M
EPS (TTM)
$-0.26
P/E Ratio
-3.83
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.99
Volume
100
Open
$0.99
Price
$0.99
Volume
100
Open
$0.99
Previous Close
$0.99
Daily Range
$0.99 - $0.99
52-Week Range
$0.73 - $3.68
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.99
Volume
100
Open
$0.99
Previous Close
$0.99
Daily Range
$0.99 - $0.99
52-Week Range
$0.73 - $3.68
GDTC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout CytoMed Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
42
CEO
Wee Kiat Tan, PhD
Website
www.cytomed.sgHeadquarters
Singapore, 149544, SG
GDTC Financials
Key Financial Metrics (TTM)
Gross Margin
-38%
Operating Margin
-10%
Net Income Margin
-11%
Return on Equity
-52%
Return on Capital
-56%
Return on Assets
-52%
Earnings Yield
-26.11%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$11.83M
Shares Outstanding
11.83M
Volume
100
Short Interest
0.00%
Avg. Volume
581.29K
Financials (TTM)
Gross Profit
$689.55K
Operating Income
$3.52M
EBITDA
$3.34M
Operating Cash Flow
$3.70M
Capital Expenditure
$703.13K
Free Cash Flow
$4.40M
Cash & ST Invst.
$2.10M
Total Debt
$482.56K
CytoMed Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$130.63K
+20.3%
Gross Profit
$432.18K
-543.7%
Gross Margin
-3.31%
N/A
Market Cap
$11.83M
N/A
Market Cap/Employee
$275.08K
N/A
Employees
43
N/A
Net Income
$1.35M
-142.3%
EBITDA
$1.73M
-237.5%
Quarterly Fundamentals
Net Cash
$1.61M
-54.0%
Accounts Receivable
$132.05K
+803.6%
Inventory
$0.00
-100.0%
Long Term Debt
$422.12K
+30.0%
Short Term Debt
$60.45K
+69.2%
Return on Assets
-51.86%
N/A
Return on Invested Capital
-55.77%
N/A
Free Cash Flow
$1.83M
-129.6%
Operating Cash Flow
$1.59M
-163.6%